This site is intended for healthcare professionals
News

FDA approves supplemental BLA for Taltz for the treatment of active non-radiographic axial spondyloarthritis.- Eli Lilly

Read time: 1 mins
Last updated:2nd Jun 2020
Published:2nd Jun 2020
Condition: Axial Spondyloarthritis
Type: drug
Register free for full access to medthority.com